Phio Pharmaceuticals Corp (NASDAQ:PHIO)

2.30
Delayed Data
As of Nov 27
 +0.06 / +2.68%
Today’s Change
1.60
Today|||52-Week Range
13.61
-75.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues34.0K19.0K15.0K138.0K
 
 
 
 
 
Depreciation And Amortization77.0K53.0K70.0K81.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses10.2M9.0M9.3M7.4M
 
 
 
 
 
Research And Development6.9M5.4M5.4M4.3M
 
 
 
 
 
Total Operating Expenses10.3M9.0M9.4M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.2M-9.0M-9.4M-7.4M
 
 
 
 
 
Extraordinary Charge0.000.00-4.7M0.00
 
 
Other Expenses-2.0K6.0K-2.0K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-9.0M-14.1M-7.4M
 
 
 
 
 
Income Taxes0.000.00-1.6M0.00
 
 
Preferred Dividend-209.0K-2.1M0.000.00
 
 
 
Net Income-10.2M-9.0M-12.5M-7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS497.0K674.6K2.3M7.0M
 
 
 
 
 
Shares To Calculate EPS Diluted497.0K674.6K2.3M7.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$21.00-$16.40-$5.52-$1.04
 
 
 
 
 
EPS Diluted-$21.00-$16.40-$5.52-$1.04